SEI Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,076
Closed -$56.4K 2799
2024
Q2
$56.4K Sell
10,076
-58
-0.6% -$325 ﹤0.01% 2578
2024
Q1
$53.1K Sell
10,134
-51,440
-84% -$270K ﹤0.01% 2566
2023
Q4
$322K Hold
61,574
﹤0.01% 2281
2023
Q3
$971K Sell
61,574
-8,438
-12% -$133K ﹤0.01% 1892
2023
Q2
$1.36M Hold
70,012
﹤0.01% 1769
2023
Q1
$1.99M Sell
70,012
-3,106
-4% -$88.1K ﹤0.01% 1627
2022
Q4
$2.14M Sell
73,118
-1,390
-2% -$40.6K ﹤0.01% 1468
2022
Q3
$1.97M Buy
74,508
+34,494
+86% +$911K ﹤0.01% 1551
2022
Q2
$1.78M Buy
40,014
+17,593
+78% +$781K ﹤0.01% 1613
2022
Q1
$1.11M Buy
22,421
+17,327
+340% +$857K ﹤0.01% 1779
2021
Q4
$259K Sell
5,094
-1,397
-22% -$71K ﹤0.01% 2385
2021
Q3
$347K Buy
+6,491
New +$347K ﹤0.01% 2254
2020
Q4
Sell
-8,264
Closed -$323K 2548
2020
Q3
$323K Buy
8,264
+1,780
+27% +$69.6K ﹤0.01% 2072
2020
Q2
$311K Sell
6,484
-571
-8% -$27.4K ﹤0.01% 2073
2020
Q1
$325K Sell
7,055
-5,107
-42% -$235K ﹤0.01% 1894
2019
Q4
$731K Sell
12,162
-1,274
-9% -$76.6K ﹤0.01% 1766
2019
Q3
$760K Buy
13,436
+2,230
+20% +$126K ﹤0.01% 1709
2019
Q2
$624K Buy
11,206
+9,985
+818% +$556K ﹤0.01% 1772
2019
Q1
$62K Sell
1,221
-116,581
-99% -$5.92M ﹤0.01% 2586
2018
Q4
$8.17M Hold
117,802
0.03% 647
2018
Q3
$8.17M Buy
117,802
+5,523
+5% +$383K 0.03% 629
2018
Q2
$8.5M Buy
112,279
+78,953
+237% +$5.97M 0.03% 653
2018
Q1
$1.76M Buy
33,326
+460
+1% +$24.2K 0.01% 1254
2017
Q4
$1.76M Buy
32,866
+6,048
+23% +$323K 0.01% 1334
2017
Q3
$1.6M Buy
26,818
+5,357
+25% +$319K 0.01% 1292
2017
Q2
$1.69M Sell
21,461
-974
-4% -$76.8K 0.01% 1259
2017
Q1
$1.86M Buy
22,435
+17,005
+313% +$1.41M 0.01% 1184
2016
Q4
$431K Buy
+5,430
New +$431K ﹤0.01% 1620
2016
Q1
Sell
-6,080
Closed -$539K 2671
2015
Q4
$539K Buy
+6,080
New +$539K ﹤0.01% 1329